These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
14. Extraosseous uptake of technetium-99m MDP in secondary deposits of neuroblastoma. Mandell GA, Heyman S. Clin Nucl Med; 1986 May; 11(5):337-40. PubMed ID: 3698433 [Abstract] [Full Text] [Related]
15. 111In-pentetreotide versus bone scintigraphy in the detection of bony metastases of neuroblastoma. Juweid ME, Menda Y, O'Dorisio MS, Bushnell D, Blake M, Madsen M, Johnson J, Graham MM. Nucl Med Commun; 2002 Oct; 23(10):983-9. PubMed ID: 12352597 [Abstract] [Full Text] [Related]
16. [Sensitivity and specificity of meta-iodobenzylguanidine (mIBG) scintigraphy in the evaluation of neuroblastoma: analysis of 115 cases]. Lumbroso J, Guermazi F, Hartmann O, Coornaert S, Rabarison Y, Lemerle J, Parmentier C. Bull Cancer; 1988 Oct; 75(1):97-106. PubMed ID: 3359060 [Abstract] [Full Text] [Related]
17. [Extraosseous tumor uptake of 99m technetium methylendiphosphonate in children with neuroblastoma (author's transl)]. Mancini AF, Turba E, Vallicelli R, Vitelli A, Fini A, Rosito P. Pediatr Med Chir; 1981 Oct; 3(6):535-9. PubMed ID: 6211661 [No Abstract] [Full Text] [Related]
18. Neuroblastoma presenting clinically as hip osteomyelitis: a "signature" diagnosis on skeletal scintigraphy. Applegate K, Connolly LP, Treves ST. Pediatr Radiol; 1995 Nov; 25 Suppl 1():S93-6. PubMed ID: 8577566 [Abstract] [Full Text] [Related]